Trends in the Use of Glucose-Lowering Therapies Among Patients at High Cardiovascular Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three decades of glucose-lowering therapy in patients at high cardiovascular risk - A real-world analysis
Diabetes Obes Metab 2024 Nov 27;[EPub Ahead of Print], M Neyer, JB Vogel, P Elsner, H Kuehrer, CH Saely, A Muendlein, A Vonbank, A Mader, A Festa, H Drexel, A LeihererFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.